Pharmacopeia Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 169

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $79M

Pharmacopeia General Information

Description

Developer of novel small molecule therapeutics intended to address significant medical needs. The company's portfolio of clinical and preclinical therapeutics, enable the physicians to address medical conditions such as hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease.

Contact Information

Formerly Known As
Pharmacopeia Drug Discovery, Pharmacopeia Drug Discovery Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • P.O. Box 5350
  • Princeton, NJ 08543
  • United States
+1 (609)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Ligand Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • P.O. Box 5350
  • Princeton, NJ 08543
  • United States
+1 (609)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmacopeia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 23-Dec-2008 $79M Completed Generating Revenue
4. PIPE 01-Aug-2005 Completed Generating Revenue
3. IPO 01-Dec-1995 Completed Generating Revenue
2. Early Stage VC 27-Jun-1994 $10.3M $10.3M Completed Product Development
1. Early Stage VC 01-Jul-1993 Completed Generating Revenue
To view Pharmacopeia’s complete valuation and funding history, request access »

Pharmacopeia Patents

  • 1,132

    Total Documents Applications and Grants

  • Total Patents Families

  • 290

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Pharmacopeia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2010135350-A2 Biphenyl intermediate compounds and methods for the preparation of a dual angiotensin ii and endothelin a receptor antagonist Inactive 20-May-2009
WO-2010135350-A3 Biphenyl intermediate compounds and methods for the preparation of a dual angiotensin ii and endothelin a receptor antagonist Inactive 20-May-2009
AU-2010210776-A1 Isoxazole-3-carboxamide derivatives Inactive 04-Feb-2009
CA-2749856-A1 Isoxazole-3-carboxamide derivatives Inactive 04-Feb-2009
EP-2393789-A1 Isoxazole-3-carboxamide derivatives Inactive 04-Feb-2009 C07D261/18
To view Pharmacopeia’s complete patent history, request access »

Pharmacopeia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmacopeia Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Avalon Ventures Venture Capital Minority
Greylock Venture Capital Minority
Highbridge Capital Management Hedge Fund Minority
IVP Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Pharmacopeia Acquisitions (2)

Pharmacopeia’s most recent deal was a Merger/Acquisition with Synomics for . The deal was made on 29-Jun-2001.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Synomics 29-Jun-2001 Merger/Acquisition Social/Platform Software
Oxford Molecular 06-Sep-2000 Merger/Acquisition Other Healthcare Services
To view Pharmacopeia’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Pharmacopeia FAQs

  • When was Pharmacopeia founded?

    Pharmacopeia was founded in 1993.

  • Where is Pharmacopeia headquartered?

    Pharmacopeia is headquartered in Princeton, NJ.

  • What is the size of Pharmacopeia?

    Pharmacopeia has 169 total employees.

  • What industry is Pharmacopeia in?

    Pharmacopeia’s primary industry is Drug Discovery.

  • Is Pharmacopeia a private or public company?

    Pharmacopeia is a Private company.

  • What is the current valuation of Pharmacopeia?

    The current valuation of Pharmacopeia is .

  • What is Pharmacopeia’s current revenue?

    The current revenue for Pharmacopeia is .

  • How much funding has Pharmacopeia raised over time?

    Pharmacopeia has raised $62.6M.

  • Who are Pharmacopeia’s investors?

    Abingworth, Avalon Ventures, Greylock, Highbridge Capital Management, and IVP are 5 of 10 investors who have invested in Pharmacopeia.

  • When was Pharmacopeia acquired?

    Pharmacopeia was acquired on 23-Dec-2008.

  • Who acquired Pharmacopeia?

    Pharmacopeia was acquired by Ligand Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process